Literature DB >> 3456460

Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County.

R K Peters, A Chao, T M Mack, D Thomas, L Bernstein, B E Henderson.   

Abstract

By hypothesizing that oral contraceptives (OC's) might have a carcinogenic effect on glandular cells of the cervix if given during periods of active metaplasia (e.g., postmenarchal adolescence), an increasing rate of cervical adenocarcinoma was predicted in young women who had been teenagers when OC's were introduced roughly 20 years ago. Secular trends for cervical carcinomas in non-Hispanic whites were examined by age, histologic type, and social class by using data from the Los Angeles County population-based tumor registry. Between 1972 and 1982, the frequency of invasive cervical adenocarcinoma in women under 35 years of age increased from about 2 to about 5 annually, amounting to an average rate of change of 8% per year (P less than .01). There was essentially no trend for women over 35 years old; the frequency of other invasive carcinomas (and of squamous carcinoma in situ) decreased at average rates of about 3% per year in women under 35 years of age and decreased more rapidly in older women. The increase in adenocarcinoma, unlike risk from cervical cancer generally, was most striking among young women residing in middle-to-upper income neighborhoods, who were the first to use OC's; in this subgroup the average rate of increase was 16% per year (P less than .05). These findings are compatible with our hypothesis and merit further study.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456460

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  16 in total

Review 1.  Cervical cancer: developments in screening and evaluation of the abnormal Pap smear.

Authors:  J M Walsh
Journal:  West J Med       Date:  1998-11

Review 2.  Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill?

Authors:  H Olsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  [Not Available].

Authors:  R Bonneau
Journal:  Can Fam Physician       Date:  1992-09       Impact factor: 3.275

4.  Cervical adenocarcinoma and oral contraceptives.

Authors:  C Chilvers; D Mant; M C Pike
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-05

5.  Decreasing rates of cervical cancer among American Indians and Hispanics in New Mexico (United States).

Authors:  A Chao; T M Becker; S W Jordan; R Darling; F D Gilliland; C R Key
Journal:  Cancer Causes Control       Date:  1996-03       Impact factor: 2.506

6.  Cervical cancer screening and registration--are they working?

Authors:  A Choyce; B R McAvoy
Journal:  J Epidemiol Community Health       Date:  1990-03       Impact factor: 3.710

7.  Semiquantitative immunohistochemical studies of blood group antigen A, B, H, Le(a), Le(b) structures and Ii backbone chains in the normal human cervix and in cervical adenocarcinoma.

Authors:  N R Griffin; M Wells
Journal:  Histochem J       Date:  1993-03

8.  Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States)

Authors:  G Ursin; M C Pike; S Preston-Martin; G d'Ablaing; R K Peters
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

9.  Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ.

Authors:  Kerstin Dreier; René Scheiden; Barbara Lener; Daniela Ehehalt; Haymo Pircher; Elisabeth Müller-Holzner; Ursula Rostek; Andreas Kaiser; Marc Fiedler; Sigrun Ressler; Stefan Lechner; Andreas Widschwendter; Jos Even; Catherine Capesius; Pidder Jansen-Dürr; Werner Zwerschke
Journal:  Virology       Date:  2010-10-23       Impact factor: 3.616

10.  Histological correlation of glandular abnormalities in cervical liquid-based cytology.

Authors:  Yosuke Kawakami; Tamaki Toda; Toshinao Nishimura; Junichi Sakane; Kazuya Kuraoka; Kazuhiro Takehara; Tomoya Mizunoe; Kiyomi Taniyama
Journal:  Patholog Res Int       Date:  2011-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.